ECS has won a 4-year, $96 million prime contract from the Department of Health and Human Services’ Advanced Research Projects Agency for Health.
This award builds on ECS’s earlier $500 million Strategic Technical ARPA-H Talent Support contract in 2024.
Under the new contract, ECS will support ARPA-H’s Health Science Futures and Scalable Solutions offices by providing programmatic services and expertise in biotechnology, neuroscience, regenerative medicine and cell therapies.
ECS will also help address challenges in healthcare access, equity and the global supply chain, while providing strategic planning, program management and financial advisory services to shape future initiatives.
“ECS is proud to support ARPA-H in forging the future of science, healthcare, and better health outcomes for our nation’s citizens. We are excited to provide foundational support to HSF and SSO, help drive healthcare system innovation, and act as a health transformation agent,” said John Heneghan, president of ECS.
Established in 2022, ARPA-H supports the development of high-impact research to drive biomedical and health breakthroughs and deliver transformative, sustainable, and equitable health solutions.
“ARPA-H is making history ― and its leaders and staff are contributing to work that will help so many people across the nation and all over the world,” said Asad Akhtar, vice president of ECS’ Federal Health practice. “ARPA-H’s HSF and SSO mission offices are performing crucial, groundbreaking research and making strides across numerous areas of biomedicine and health. We are honored to play a part in this mission and this moment.”